Division of Sublicensing Fees and Other Payments Sample Clauses

Division of Sublicensing Fees and Other Payments. In consideration for the valuable nature of the Patent Rights, Know-How and Improvements and the access to potential new partners they will give to KI PHARMA, (i) in the event a sublicense fee or other up-front or milestone payment amount due on or before the relevant NDA Approval (collectively, the "Up-front Payment") is paid by any Sublicensee or other third party for distribution, marketing and/or sales rights to a Venture Product BN in the Territory, then [**], and (ii) in the event the Up-front Payment is paid by any Sublicensee or other third party for distribution, marketing and/or sales rights to a Venture Product GR in the Territory, then [**]. All royalty payments due after the relevant NDA Approval (the "Royalties") and any additional amounts received from any Sublicensee or other third party in connection with a Venture Product being sold by or for the benefit of KI PHARMA [**].
Sample 1Sample 2
AutoNDA by SimpleDocs
Division of Sublicensing Fees and Other Payments. In consideration for the valuable nature of the Patent Rights, Know-How and Improvements and the access to potential new partners they will give to KI PHARMA, (i) in the event a sublicense fee or other up-front or milestone payment amount due on or before the relevant NDA Approval (collectively, the "Up-front Payment") is paid by any Sublicensee or other third party for distribution, marketing and/or sales rights to a Venture Product BN in the Territory, then BIONUMERIK will be paid [**] of such payment and GRELAN will be paid [**] of such payment, and (ii) in the event the Up-front Payment is paid by any Sublicensee or other third party for distribution, marketing and/or sales rights to a Venture Product GR in the Territory, then GRELAN will be paid [**] of such payment and BIONUMERIK will be paid [**] of such payment. All royalty payments due after the relevant NDA Approval (the "Royalties") and any additional amounts received from any Sublicensee or other third party in connection with a Venture Product being sold by or for the benefit of KI PHARMA to a Japanese wholesaler, distributor, hospital, or pharmacy, after payment of the manufacturing price, Royalties, and Up-front Payments, shall be paid [**] to GRELAN and [**] to BIONUMERIK.
Sample 1Sample 2

Related to Division of Sublicensing Fees and Other Payments

  • Royalties and Other Payments A. For the rights, privileges and exclusive license granted hereunder, Licensee shall pay to CMCC the following amounts in the manner hereinafter provided. Unless expressly stated otherwise in this Agreement, periodic payment obligations listed below shall endure through the Term of this Agreement, unless this Agreement shall be sooner terminated as hereinafter provided.

  • Fees, Expenses and Other Payments (a) Except as otherwise provided in this Section 7.3, whether or not the Merger is consummated, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby (including, without limitation, fees and disbursements of counsel, financial advisors and accountants) shall be borne solely and entirely by the party which has incurred such costs and expenses (with respect to such party, its "Expenses").

  • Payments Fees and Other General Provisions Section 3.1.

  • Expenses and Other Payments (a) Except as otherwise provided in this Section 8.3, each party shall pay its own expenses incident to preparing for, entering into and carrying out this Agreement and the consummation of the Transactions, whether or not the Merger shall be consummated.

  • Taxes and Other Payments 7.1. Unless otherwise specifically provided for in this Agreement, the Company shall not be liable for the payment of taxes or other payments for which the Employee is responsible as result of this Agreement or any other legal provision, and the Employee shall be personally liable for such taxes and other payments.

  • COMPENSATION AND OTHER FEES As compensation for the services provided by Xxxxxx xxxxxxxxx, the Company agrees to pay to Xxxxxx:

  • Payment of Transfer Taxes, Fees and Other Expenses The Company agrees to pay any and all original issue taxes and stock transfer taxes that may be imposed on the issuance of shares received by an Employee in connection with the Restricted Stock Units, together with any and all other fees and expenses necessarily incurred by the Company in connection therewith.

  • Improper and Other Payments (a) Neither the Company, any director, officer, employee thereof, nor any agent or representative of the Company nor any person acting on behalf of any of them, has made, paid or received any unlawful bribes, kickbacks or other similar payments to or from any person or authority, (b) no contributions have been made, directly or indirectly, by the Company to a domestic or foreign political party or candidate; and (c) the internal accounting controls of the Company are believed by the Company’s management to be adequate to detect any of the foregoing under current circumstances.

  • Handling Fees and Other Expenses All fees and out of pocket expenses relating to this Agreement, including but not limited to legal costs, costs of production, stamp tax and any other taxes and fees, shall be borne by Party C.

  • Field Examination and Other Fees Subject to any limitations set forth in Section 5.7(c), Borrowers shall pay to Agent, field examination, appraisal, and valuation fees and charges, as and when incurred or chargeable, as follows (i) a fee of $1,000 per day, per examiner, plus out-of-pocket expenses (including travel, meals, and lodging) for each field examination of any Loan Party or its Subsidiaries performed by or on behalf of Agent, and (ii) the fees, charges or expenses paid or incurred by Agent if it elects to employ the services of one or more third Persons to appraise the Collateral, or any portion thereof.

Time is Money Join Law Insider Premium to draft better contracts faster.